NCT02788591View on ClinicalTrials.gov

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Non-erosive Reflux DiseaseGastroesophageal Reflux
Interventions
DRUG

Proton Pump Inhibitor (PPI) Therapy

Subject will take a proton pump inhibitor (PPI) of their choice (Omeprazole, Esomeprazole, Pantoprazole, or Lansoprazole) 2 times a day for 8 weeks.

DRUG

Sucralfate

Subject will take Sucralfate 4 times a day for 8 weeks.

Trial Locations (2)

70112

Touro Infirmary New Orleans, New Orleans

University Medical Center New Orleans, New Orleans

Sponsors

Lead Sponsor

LCMC Health
All Listed Sponsors
lead

LCMC Health

OTHER

NCT02788591 - Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection | Biotech Hunter | Biotech Hunter